Time to Next Treatment Within 24 Months ( <scp>TTNT24</scp> ) as a Predictor of Survival in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia: A Population‐Based Observational Study
TTNT24 and TTLT24 may serve as dynamic prognostic markers in real-world LPL/WM populations. Their relevance in the era of targeted therapies warrants further investigation.
Authors
- Lars Møller Pedersen (ORCID: https://orcid.org/0000-0002-9419-8841)
- Lise Mette Rahbek Gjerdrum (ORCID: https://orcid.org/0000-0003-4377-3209)
- Lars Munksgaard (ORCID: https://orcid.org/0009-0007-5553-7269)
- A. Munksgaard
Institutions
- University of Copenhagen (DK)
- Zealand University Hospital (DK)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1111/ejh.70073
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Region Sjælland
- Common Fund